Flurbiprofen Te Mouthwash 160 Ml | Buy Online at Farmaclick

Symptomatic treatment of irritative-inflammatory conditions, including those associated with pain in the oropharyngeal cavity (e.g., gingivitis, stomatitis, pharyngitis), also following conservative or extraction dental therapy.

Active ingredients

FLURBIPROFENE TEVA 0.25% Mouthwash 100 ml of solution contain: Active ingredient: Flurbiprofen 0.25 g FLURBIPROFENE TEVA 0.25% Oromucosal spray 100 ml of solution contain: Active ingredient: Flurbiprofen 0.25 g Excipients with known effects: ethanol 8.64 g methyl p-hydroxybenzoate 0.10 g propyl p-hydroxybenzoate 0.02 g polyoxyethylene hydrogenated castor oil-40 2.00 g patent blue V dye (E131) 0.0006 g For the full list of excipients, see paragraph 6.1

Excipients

FLURBIPROFENE TEVA 0.25% Mouthwash and FLURBIPROFENE TEVA 0.25% Oromucosal spray Glycerol (98%), ethanol, non-crystallizable liquid sorbitol, polyoxyethylene hydrogenated castor oil-40, sodium saccharin, methyl parahydroxybenzoate, propyl parahydroxybenzoate, mint flavoring, patent blue V (E131), anhydrous citric acid, sodium hydroxide, purified water.

Warnings

At the recommended doses, any swallowing of FLURBIPROFENE TEVA 0.25% Mouthwash and FLURBIPROFENE TEVA 0.25% Oromucosal spray will not cause any harm to the patient, as such doses are far lower than those of the single dosage of the product for systemic use. During the first and second trimesters of pregnancy, flurbiprofen should not be administered unless strictly necessary (see paragraph 4.6). Administration of flurbiprofen is not recommended in breastfeeding mothers (see paragraph 4.6). The use of FLURBIPROFENE TEVA 0.25% Mouthwash and FLURBIPROFENE TEVA 0.25% Oromucosal spray, especially if prolonged, may give rise to sensitization or local irritation phenomena; in such cases, treatment must be discontinued and a physician consulted to establish, if necessary, appropriate therapy. Do not use for prolonged treatments. After short periods of treatment without significant results, it is necessary to check the patient. In patients with renal, cardiac, or hepatic insufficiency, the product must be used with caution. It is advisable not to combine the product with other NSAIDs. Cases of bronchospasm with flurbiprofen have been reported in patients with a history of bronchial asthma. Gastrointestinal Effects Flurbiprofen should be administered with caution to patients with a history of peptic ulcer and other gastrointestinal diseases, as these conditions may be exacerbated. The risk of gastrointestinal hemorrhage, ulcer, or perforation is higher with increasing flurbiprofen dosage in patients with a history of ulcer, particularly if complicated by hemorrhage and perforation, and in the elderly. These patients should start treatment with the lowest available dose. Gastrointestinal hemorrhage, ulcer, or perforation have been reported with all NSAIDs at any time during treatment. These adverse events can be fatal and can occur with or without warning symptoms or in case of a previous history of serious gastrointestinal events. Patients with a history of gastrointestinal diseases, especially if elderly, must report any unusual abdominal symptoms (especially gastrointestinal hemorrhage) in the initial stages of treatment. Elderly patients have an increased frequency of adverse reactions to NSAIDs, especially gastrointestinal hemorrhage and perforation, which can be fatal. Undesirable effects can be minimized by using the lowest effective dose for the shortest duration of treatment necessary to control symptoms (see paragraph 4.2). Important information about some excipients The mouthwash and oromucosal spray contain para-hydroxybenzoates which may cause allergic reactions (possibly delayed). The patent blue V dye (E131) may cause allergic reactions. Polyoxyethylene hydrogenated castor oil-40 may cause localized skin reactions. Both the mouthwash and the spray contain a small amount of ethyl alcohol, less than 100 mg per dose.

Overdose

Symptoms of overdose may include nausea, vomiting, and gastrointestinal irritation.